Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) used in the treatment of immune disorders. It is used in combination with other drugs to treat HIV/AIDS, hepatitis B, and other immune disorders. It works by blocking the action of reverse transcriptase, an enzyme that is essential for the replication of HIV and other viruses. Emtricitabine is also used to prevent the transmission of HIV from mother to child during pregnancy.
Emtricitabine is available in both oral and injectable forms. It is generally well tolerated, with few side effects. Common side effects include nausea, headache, and fatigue. Serious side effects are rare, but can include liver damage and allergic reactions.
Emtricitabine is marketed by several pharmaceutical companies, including Gilead Sciences, Bristol-Myers Squibb, and Merck. It is also available in generic form from several generic drug manufacturers. Show Less Read more
